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The human gut microbiome is known to be asso-
ciated with various human disorders, but a major
challenge is to go beyond association studies and
elucidate causalities. Mathematical modeling of the
human gut microbiome at a genome scale is a useful
tool to decipher microbe-microbe, diet-microbe and
microbe-host interactions. Here, we describe the
CASINO (Community And Systems-level INteractive
Optimization) toolbox, a comprehensive computa-
tional platform for analysis of microbial communities
through metabolic modeling. We first validated the
toolbox by simulating and testing the performance
of single bacteria and whole communities in vitro.
Focusing on metabolic interactions between the
diet, gut microbiota, and host metabolism, we
demonstrated the predictive power of the toolbox
in a diet-intervention study of 45 obese and over-
weight individuals and validated our predictions by
fecal and blood metabolomics data. Thus, modeling
could quantitatively describe altered fecal and serum
amino acid levels in response to diet intervention.
INTRODUCTION
Increasing evidence indicates that changes in the composition
of the human gut microbiota affect host metabolism and are
associated with a variety of diseases (Ba¨ckhed et al., 2005;
Qin et al., 2014). Changes in diet have been shown to rapidly
affect the composition of the gut microbiota (David et al., 2014;
Wu et al., 2011). Furthermore, microbiota-diet interactions
impact host physiology through the generation of a number of320 Cell Metabolism 22, 320–331, August 4, 2015 ª2015 Elsevier Incbioactive metabolites (Cotillard et al., 2013; Le Chatelier et al.,
2013; Nicholson et al., 2012; Wu et al., 2014). For example,
short-chain fatty acids (SCFAs), which are generated bymicrobi-
al fermentation of dietary polysaccharides in the gut, are an
important energy source for colonocytes and also function as
signaling molecules, modulating intestinal inflammation and
metabolism (Donohoe et al., 2011; Fernandes et al., 2014;
Samuel et al., 2008; Smith et al., 2013b; Tolhurst et al., 2012).
In addition, dietary proteins and amino acids are important
substrates for microbial fermentation in the colon (Cummings
and Macfarlane, 1997), where they also serve as an important
nitrogen source for the microbiota and support the growth of
the microbiota and the host (Wu, 2009).
By quantifying the release and consumption of metabolites by
the gut microbiota, it may be possible to elucidate interactions
between the gut microbiota and host metabolism (Tremaroli
and Ba¨ckhed, 2012). This information would allow identification
of diagnostic biomarkers and may provide insight into the role
of the gut microbiota in disease progression (Karlsson et al.,
2013; Qin et al., 2014; Zeller et al., 2014). A predictive sys-
tems-level model of the human gut microbiome is required
to elucidate causalities and quantify the interactions between
microbes, host, and diet (Greenblum et al., 2013; Manor et al.,
2014; Shoaie and Nielsen, 2014).
A genome-scale metabolic model (GEM) is an integrative
platform for exploring genotype-phenotype relationships and
metabolic differences between different clinical conditions
(Ghaffari et al., 2015; Henry et al., 2010; Mardinoglu et al.,
2014; Mardinoglu and Nielsen, 2015; Monk et al., 2014; Shoaie
and Nielsen, 2014). We previously reconstructed GEMs to
study the interactions between Bacteroides thetaiotaomicron
and Eubacterium rectale (Shoaie et al., 2013), representatives
of Bacteroidetes and Firmicutes, the two dominant phyla in
the human gut (Huttenhower et al., 2012), and between
Bifidobacterium adolescentis and Faecalibacterium prausnitzii
(El-Semman et al., 2014), also dominant and dietary-responsive.
gut microorganisms (Walker et al., 2011). In both studies, we
manually identified the interactions between the bacteria and
quantified the consumption and production rates of the defined
interacting metabolites for each bacterial species. Although
other studies have been conducted for communities of two
and three species (Harcombe et al., 2014; Zomorrodi and Mara-
nas, 2012), these approaches cannot be expanded to simulate
the interactions of a large number of species representing the
complex gut ecosystem. Therefore, we developed the CASINO
(Community And Systems-level INteractive Optimization)
toolbox, which comprises an optimization algorithm integrated
with diet analysis to predict the phenotypes and related dietary
intake within the human gut microbiota. The toolbox was tested
using both data from in vitro experiments and results from a
nutritional intervention study of subjects with varying gut micro-
bial gene richness.
RESULTS
CASINO Toolbox
We first developed an optimization algorithm in the CASINO
toolbox, which is based on a collaborative and a multi-dimen-
sional distributed approach (Grimm et al., 2005). It takes into
account both collaboration between the multiple species and
the fact that each individual species seeks to optimize its growth
individually. Although GEMs are linear models, the presence
of several GEMs in the overall community model means that
the optimization of community biomass production becomes a
non-linear problem. Therefore, we separated the community
model into systems level (representing the community) and
organism level (representing each species), which allowed us
to linearize the optimization problem.
Simulations using CASINO start with an initialization stage that
defines a primary profile of the systems-level topology (i.e.,
which species are present and how do they interact). This leads
to the construction of a community matrix that defines effectors
and receptors, with effectors being species that produce
metabolites and receptors being species that consumemetabo-
lites. Following definition of the topology, the initialization step
calculates metabolite production by each species using organ-
ism-level optimization. Thereafter, CASINO performs iterative
multi-level optimization to calculate the relative uptake of carbo-
hydrates by each species, until the total community biomass
production is optimized. In this study, this calculation is con-
strained by the relative abundance of each species (Figure S1;
Experimental Procedures).
To evaluate CASINO, we used the RAVEN toolbox (Agren
et al., 2013) to update and significantly expand the content
of our previously published GEMs for B. thetaiotaomicron,
E. rectale, B. adolescentis, and F. prausnitzii and to generate a
GEM for Ruminococcus bromii, a representative of Clostridiales
and a key gut symbiont (Ze et al., 2012). All GEMs were manually
curated for functionality based on literature information. We
defined a set of metabolic tasks, e.g., generation of biomass pre-
cursors (Table S1), to further investigate the functionality of the
GEMs and checked that the resulting models could perform
the defined tasks (Experimental Procedures).
The GEMswere functionally validated using experimental data
for each of the five bacteria. We quantified the abundance of theCelbacteria by 16S rRNA qPCR at baseline and after 24 hr of growth
in selected media (Table S2; Supplemental Experimental Proce-
dures). We performed targeted metabolomics to quantify
products of the fermentative activity of the studied bacteria; spe-
cifically, the SCFAs butyrate, acetate, and propionate and 15
different amino acids, as well as consumption of carbohydrates
(glucose, maltose, cellobiose, and starch). Flux constraints were
imposed using the metabolomics profiles of the growth media,
and maximum growth of each bacterial species was set as an
objective function to simulate the predictive power of the corre-
sponding model (Figure 1A; Experimental Procedures). The
experimental data confirmed that the GEMs predicted the meta-
bolism and biomass growth for each bacterial species (Figures
1B–1D). The GEMs correctly predicted that acetate can be pro-
duced by B. adolescentis, B. thetaiotaomicron, and R. bromii;
butyrate can be produced by E. rectale and F. prausnitzii; and
propionate can only be produced by B. thetaiotaomicron (Fig-
ure 1B). Our simulations also predicted that these five bacteria
synthesize significantly higher levels of essential amino acids
(valine, leucine, methionine, lysine, and phenylalanine)
compared to non-essential amino acids (serine, tyrosine, and
threonine) (Figure 1D).
Revealing the Interactions between Constituents of
In Vitro Microbial Communities
To test the performance of CASINO, we simulated the interac-
tions between the microbes in two microbial communities that
differed only in one bacterial species: EBBR (E. rectale,
B. adolescentis, B. thetaiotaomicron, and R. bromii) and FBBR
(F. prausnitzii, B. adolescentis, B. thetaiotaomicron, and
R. bromii) (Figure 2A). The simulated values were validated
by culturing EBBR and FBBR communities in selected media.
We quantified the abundance of individual bacterial species
in each community by 16S rRNA-based qPCR (Table S3). We
also performed targeted metabolomics to quantify the pro-
duction of SCFAs and amino acids and the consumption of
carbohydrates (starch and cellobiose) for each community
(Supplemental Experimental Procedures).
Our model simulations correctly predicted the net production
of the metabolites produced by each community and showed
that the communities synthesized more essential amino acids
than non-essential amino acids (Figure 2B). More importantly,
the simulations enabled quantification of the contribution of
each individual bacterial species to the overall microbial conver-
sion in the communities and showed that two of the species in
each community dominated. Specifically, we predicted that
B. thetaiotaomicron and E. rectale synthesized 41% and 36%
of the amino acids in the EBBR community, respectively, and
that B. thetaiotaomicron and F. prausnitzii synthesized 39%
and 47% of the amino acids in the FBBR community, respec-
tively (Figure S2). We also predicted that E. rectale mainly
contributed to the synthesis of valine, leucine, phenylalanine,
and methionine in the EBBR community, while F. prausnitzii
was the major contributor to the production of valine and leucine
in the FBBR community. Furthermore, the experimental data
showed that substitution of E. rectale with F. prausnitzii
decreased the level of butyrate in the media, due to the higher
capacity of E. rectale for butyrate production (Louis et al.,
2010), and also the model simulations showed a slightly lowerl Metabolism 22, 320–331, August 4, 2015 ª2015 Elsevier Inc. 321
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Figure 1. Validation of the GEMs
(A) Each GEM was validated based on the rRNA and metabolomics data generated by in vitro experiments. The byproducts and the substrate usage were
constrained in the models, and the growth rate was compared with the experimental data.
(B) Predicted and measured SCFA levels by the individual bacteria. Propionate was produced only by B. thetaiotaomicron, while acetate was produced by
Actinobacteria and Bacteroidetes phyla. Butyrate production was mainly produced by the bacteria from the class Clostridia.
(C) Predicted and measured biomass at the end of the fermentations. Growth was set as an objective function for each model, and the predicted growth was
compared with the experimental data.
(D) Predicted and measured levels of amino acids by the individual bacteria. Each model also predicted amino acid levels, and the details of 15 significant amino
acids produced are shown for each bacterium. The predicted and experimental values showed that all amino acids could be produced in the range of exper-
imental data with specific optimum solution.
Data are presented as mean ± SD.
See also Tables S1 and S2.butyrate production by the FBBR community compared with the
EBBR community.
Next, we calculated the centrality scores for each bacterial
species to identify which species have a dominant role in the
overall metabolic conversion in each community (Supplemental
Experimental Procedures). We observed that E. rectale and
B. thetaiotaomicron were the main receptor and effector,
respectively, and thus represent key species (Figure 3A). We
then evaluated the sensitivity of the optimization algorithm in
CASINO by adding bacteria in three steps to each of these
two bacteria, culminating in the reconstruction of the two
in vitro communities. We calculated the SCFA levels for each
step (Figure 3B). Addition of B. adolescentis to E. rectale in
the EBBR community resulted in reduced production of buty-322 Cell Metabolism 22, 320–331, August 4, 2015 ª2015 Elsevier Incrate and increased production of propionate and acetate.
Addition of F. prausnitzii to B. thetaiotaomicron in the FBBR
community resulted in reduced production of propionate and
acetate and increased butyrate production. The levels of the
SCFAs changed further when the other species were added
(Figure 3B).
Analyzing the Effect of Gene Richness and Diet on Gut
Microbiota Composition
To further evaluate CASINO, we examined data from a clinical
study where 45 overweight and obese individuals were sub-
jected to an energy-restricted, high-protein diet with low glyce-
mic index for 6 weeks (Figure 4A; clinical data in Table S4). These
patients had previously been stratified based on their gut.
A B
Figure 2. Validation of the CASINO Toolbox
(A) Two in silico microbial communities, EBBR (E. rectale + B. adolescentis + B. thetaiotaomicron + R. bromii) and FBBR (F. prausnitzii + B. adolescentis +
B. thetaiotaomicron + R. bromii), were designed and simulated using the CASINO Toolbox. The results were compared with data from triplicate in vitro ex-
periments for EBBR and FBBR communities. In CASINO, the interactions of the bacteria as well as the phenotype of the community were identified using an
optimization algorithm.Growth of each bacterium had local optimum,whereas the community had global optimum. The community optimumwas detected by the
intersection point of the fixed constraints for the community and the calculated dynamic constraints, which was obtained by summation of the local and
community forces.
(B) Predicted and measured levels of SCFA and amino acids by the two in-silico microbial communities including EBBR (E. rectale, B. adolescentis,
B. thetaiotaomicron, and R. bromii) and FBBR (F. prausnitzii, B. adolescentis, B. thetaiotaomicron, and R. bromii). We found that synthesis of essential amino
acids (histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, and valine) produced by the communities is higher than the production of non-
essential amino acids (alanine, glutamate, glycine, proline, serine, and tyrosine).
Data are presented as mean ± SD.
See also Figures S1 and S2 and Table S3.microbial gene richness into ‘‘low gene count’’ (LGC; n = 18) and
‘‘high gene count’’ (HGC; n = 27), based on a cutoff threshold of
480,000 genes (Cotillard et al., 2013). LGC demonstrated a
worse metabolic profile compared with HGC individuals (Cotil-
lard et al., 2013).
Analysis of metagenomics data before and after the diet inter-
vention showed that six species dominated in all subjects:
Escherichia coli and F. prausnitzii and four species associated
with Clostridia, Bacteroides, Bifidobacteria, and Lactobacillus
(Cotillard et al., 2013). To obtain quantitative data of these
species, we analyzed fecal samples by 16S rRNA qPCR before
and after the dietary intervention (Table S5; Supplemental
Experimental Procedures) and used these results to calculate
the distribution of biomass between the species (Figure 4B).
We observed significant differences in abundance for
B. adolescentis, F. prausnitzi, and E. rectale at baseline and
for B. adolescentis and L. reuteri after 6 weeks between
LGC and HGC individuals. In HGC individuals, levels of
B. thetaiotaomicron significantly increased and L. reuteri andCelF. prausnitzii significantly decreased after 6 weeks of dietary
intervention compared with baseline, whereas a significant
decrease in LGC individuals was only seen for L. reuteri.
Diet Interventions Alter Amino Acid and SCFA Levels in
HGC and LGC Individuals
To simulate the effect of the diet on the overall gut microbiota
metabolism, we used representatives of the most abundant
microbial groups that we had also modeled in vitro, i.e.,
B. thetaiotaomicron, B. adolescentis, F. prausnitzi, E. rectale as
described earlier, and Lactobacillus reuteri, for which we recon-
structed a GEM. We also performed simulations with inclusion
of E. coli, but as this species had nomajor impact on the produc-
tion of SCFAs and amino acids (data not shown), we did not
include this species in our further analysis. Using CASINO, we
simulated the effect of diet on the human gut microbiota com-
position at baseline and after the dietary intervention for 44 of
the subjects (registered diet information in Table S6). To translate
the diets into metabolites that can be utilized by the five gutl Metabolism 22, 320–331, August 4, 2015 ª2015 Elsevier Inc. 323
AB
Figure 3. The Network Structure Influence
and Sensitivity Analysis on CASINO
(A) The community of B. thetaiotaomicron,
B. adolescentis, F. prausnitzii, E.rectale, and
R.bromii were tested based on being receptors
(receiving metabolites from the other microbes) or
effectors (producingmetabolites where consumed
by receptors). Two methods of centrality were
tested on these networks (power centrality and
degree centrality). Calculated centrality scores
determined E. rectale as the most important
receptor and B. thetaiotaomicron as the most
important effector.
(B) The sensitivity of CASINO optimization was
tested by evaluating the changes in the SCFA
profile upon adding different species to the
community. First, the most important receptor
and effector in the communities were identified
using the result of Figure 3A. 1 mmol/l of glucose
was used for all the simulations, and the SCFA
profiles were predicted. Following identification
of the dominant receptor and effector, the key
species, the other species were added to the
community one by one until the EBBR and FBBR
communities were reconstructed. Comparison
between the simulations showed that the SCFA
profile is very sensitive of the absence and pres-
ence of species with respect to their abundance
and interactions.bacterial species, we computed the dietary macronutrients of 24
different food items (Table S7) and used this information in a
diet allocation algorithm in CASINO. With this algorithm,
CASINO predicted that there was a decrease in carbohydrate
consumption and an increase in amino acid consumption for
all individuals after 6 weeks of dietary intervention (Figure 4C).
The intake of fiber from bread and potatoes—and, to a lesser
extent, from rice, cereals, and snacks—was decreased, but
fiber from fruits and vegetables was increased in agreement
with the dietary recommendation given to the patient during
the intervention (Figure 4C).
For the simulations, we assumed that carbohydrates and
fibers were hydrolyzed to glucose to the same degree in all sub-
jects, allowing us to calculate the relative amount of glucose
available to the gut microbiome in each subject. We further
assumed that glucose was the limiting substrate for the gut
microbiome. We first used CASINO to quantify the community
interactions and the relative glucose uptake by the individual
species. We used the calculated values of species abundance
in this process. Thereafter, we used CASINO to repeat the
simulations but now allowing the individual species to consume
amino acids in the same ratio as their glucose uptake. The
amount of available amino acids was calculated from the diet
composition using CASINO.
With this approach, we could simulate the profile of three
SCFAs and 14 amino acids produced by the gut ecosystem,
as well as the contribution of each microbial species to the
overall metabolite production of the ecosystem at baseline and
after 6 weeks of dietary intervention for each individual. By
plotting average profiles for all the subjects, we found that324 Cell Metabolism 22, 320–331, August 4, 2015 ª2015 Elsevier Incthe levels of the SCFAs and amino acids produced by the gut
microbiota were significantly decreased after dietary interven-
tion when both LGC andHGC groups were combined (Figure 5A,
decrease in the y axis direction), but the greatest reductions
were observed in LGC individuals (Figure 5A, increase in the x
axis direction).
To experimentally evaluate our predictions on altered metab-
olite production by the gut ecosystem, we performed metabolo-
mics analysis of fecal samples obtained from the HGC and LGC
individuals at baseline and after 6 weeks of dietary intervention.
These data confirmed many of the predicted simulations by
CASINO, i.e., alanine, proline, glycine, serine, phenylalanine,
and tyrosine all showed decreased levels in response to the
diet intervention in both HGC and LGC subjects but with a larger
decrease in the LGC subjects (Figure 5B, shift down-ward right).
To test the significance of these changes for each group of sub-
jects and between the two time points, we calculated p values
using a Student’s t test, and, except for alanine, these changes
were significant for the different groups (Figure 5C). Measured
serine levels were significantly higher in LGC than in HGC individ-
uals at baseline but not after 6 weeks of dietary intervention
(Figure 5B), in agreement with the predicted results (Figure 5A).
Also, measured phenylalanine levels were significantly higher
in LGC individuals than in HGC individuals at baseline but lower
in LGC individuals compared to HGC subjects after 6 weeks of
dietary intervention, in agreement with predicted results.
In addition to predicting changes in some of the metabolites in
response to dietary intervention, the model could also be used
to predict the relative contribution of each bacterial species to
production of specific metabolites, allowing us to quantitatively.
access how a variation in the gut microbiome correlates with
metabolite production. Thus, we predicted the contribution of
each bacterial species to phenylalanine levels in the gut
ecosystem and showed that 23% of the total phenylalanine is
produced by B. adolescentis and 26% by E. rectale in HGC
individuals at baseline, while this contribution increased for
B. adolescentis to 26% and decreased for E. rectale by 21%
after 6 weeks of dietary intervention (Figure S3). For LGC individ-
uals, the contribution of E. rectale to phenylalanine production
was 29% at baseline and decreased to 15% after 6 weeks of di-
etary intervention (Figure S3).
Serum Metabolomics Confirm Model Predictions and
Associate with Clinical Parameters
Although the model simulations could correctly predict
changes in several of the metabolites in the feces, we noted
that the model simulations did not accurately predict changes
in all the measured metabolites, which may be a result of
differential absorption by the host. Therefore, we evaluated
whether the model could predict changes in the serum. We
used metabolomics to analyze serum of the 45 subjects at
baseline and after 6 weeks of dietary intervention and found
an excellent correspondence between the model predictions
(Figure 5A) and the measured changes (Figure 6A). The serum
levels of ten detected amino acids decreased in response to
the dietary intervention in the LGC subjects (Figure 6A).
Furthermore, in agreement with the model predictions, there
was a decrease in acetate in response to the diet intervention
in all subjects (Figure 6A). In addition, we observed that phenyl-
alanine levels were higher in LGC subjects, compared to HGC
subjects at baseline, but that the level of phenylalanine
decreased in LGC subjects after 6 weeks of dietary intervention
(Figures 6A and 6B). We also observed that levels of valine,
leucine, and alanine were higher in LGC subjects at baseline
(Figures 6A and 6B).
To evaluate whether these changes in serummetabolite levels
may have any clinical relevance, we analyzed the correlations
between the levels of the ten amino acids in the serum and
bioclinical parameters of the subjects at baseline (Figure 6C).
Here, we found that the serum phenylalanine levels were
positively correlated with clinical variables related to body
corpulence (BMI [body mass index], DXA [dual-energy X-ray
absorptiometry]-measured fat mass, waist circumference, lep-
tin), insulin resistance, blood lipid homeostasis (serum triglycer-
ides and cholesterol), and low-grade inflammation (human
sensitive C-reactive protein; hsCRP). The serum levels of valine
and leucine were also positively correlated with BMI.
Model-Based Diet Design to Improve Metabolism
of LGC Individuals
Finally, assuming that LGC subjects have a non-optimal gut
microbiome metabolism (associated with a clinically altered
metabolism) we wanted to identify which dietary change would
improve the metabolism of their gut microbiome. Therefore, we
made the assumption that an adapted dietary recommendation
in LGC subjects provided at baselinewould enable them to reach
the ‘‘optimal’’ gut microbiome metabolism of HGC subjects after
6 weeks of dietary intervention, which is, indeed, associated with
an improved metabolic phenotype.CelWe then used CASINO and the abundance of the five different
species, i.e., B. thetaiotaomicron, B. adolescentis, F. prausnitzi,
E. rectale, and L.reuteri, to predict the relative consumption of
eight essential amino acids by the gut microbiome in the LGC
subjects at baseline (base phenotype in Figure 7A) and in the
HGC subjects at week 6 (improved phenotype in Figure 7A).
From this model analysis, we found that the gut microbiome
of HGC individuals had a higher consumption of these eight
essential amino acids at week 6 compared to that of the LGC
subjects at baseline. An incremental augmentation of these
amino acids would permit to acquire a similar metabolism of
the gut microbiome in LGC and HGC subjects (Figure 7A).
Many different combinations of food sources could fulfill such a
requirement for essential amino acids. However, in an attempt
to identify some overall guidelines, we correlated the difference
between the two different requirements of amino acids with
the composition of these amino acids in different food types
(Table S8). This showed that LGC individuals should significantly
increase consumption of dairy products, vegetables, whitemeat,
fish pulses, eggs, oils, and butter. In the meantime, they should
considerably reduce intake of pastries, bread, and rice to
improveandslightly reduce intakeof cereals andnuts (Figure7B).
DISCUSSION
The overall metabolism of the gut microbiome can bemodeled in
one of twoways: (1) by using a lumpedmodel of all the metabolic
reactions active in the different gut microorganisms or (2) by
compartmentalizing the metabolism according to the individual
microorganisms. The latter is clearly a better reflection of the
true biological system, and it also ensures that redox and energy
balances are constrained within each organism considered.
Therefore, we used this approach to model the metabolism of
the human microbiome and reconstructed GEMs for individual
species from the predominant phyla in the human gut. We iden-
tified which species to include in our analysis based on their
abundance in the gut ecosystem. Thus, we reconstructed
GEMs for five species that are representative bacteria of the
dominant phyla in the human gut, and we hypothesized that
the reactions included in our models cover most of themetabolic
functions that are present in the human gut. Compared with
earlier attempts to model the human gut metabolism using
GEMs, i.e., the COMETS algorithm (Harcombe et al., 2014),
CASINO allows inclusion of several species in the simulations.
Furthermore, it is scalable and enables expansion to include
even more than the five species that we considered in this study.
To evaluate whether we are covering the main metabolic
functions, we simulated the effect of different diets, studied
the interactions between the microbes and host in response
to the diet, and quantified the contribution of each bacterial spe-
cies to the fecal metabolite profiling. The model simulations
matched fecal metabolomics data, but more importantly, it
correctly correlated with changes in serum levels of ten amino
acids and one SCFA (acetate). Thus, the model captures some
major metabolic functions of the human gut microbiome. In the
future, the selection of species to be considered should be
expanded, in particular, to ensure representation of more spe-
cific metabolic functions, such as vitamin biosynthesis and bile
acid metabolism.l Metabolism 22, 320–331, August 4, 2015 ª2015 Elsevier Inc. 325
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Figure 4. The Effect of the 6-Week Diet Interventions in HGC and LGC Individuals
(A) For each food source, the major macronutrients were quantified, and this enabled using the CASINO Toolbox to study the effect of the diet on the gut
microbiota composition of subjects classified on the basis of on their microbial gene richness.
(legend continued on next page)
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Figure 5. The Effect of the 6-Week Diet In-
terventions in Predictions and Fecal Metab-
olomics of HGC and LGC Individuals
(A) Summary of average phenotypic predictions for
baseline and after 6 weeks. The group of metab-
olites at the top right denotes the predictions at
baseline, and the group at the bottom left repre-
sents predictions after 6 weeks of dietary inter-
vention. Subtracting the log10 average metabolite
fluxes for HGC from LGC is represented on the
x axis, and the summation is represented on the
y axis. The x axis shows the ratio of predicted
metabolite levels between HGC and LGC, and the
y axis shows the sum of predicted metabolite
levels in the two groups. The colors show the
metabolites’ distance from zero on the y axis (from
dark blue at the top to dark red at the bottom).
(B) Metabolomics analysis of fecal samples ob-
tained from HGC and LGC subjects. The differ-
ences are shown for 14 detected amino acids as
well as for butyrate.
(C) p values based on Student’s t test for specifi-
cation of significantly changed metabolites for four
different comparisons.The consistency between model predictions of metabolite
productions and measurement of changes in metabolite levels
in feces and serum suggests that ourmodeling correctly predicts
the overall carbon fluxes in the gut ecosystem. Furthermore, our
simulations enabled quantification of how the individual species
compete for nutrients and produce different metabolites that
may serve as nutrients for other species or be absorbed by the
host. Studying the gut metabolism with our holistic approach(B) Abundance of species before and after diet interventions in HGC and LGC subjects. Data are shown as box
B. adolescentis (jade), L. reuteri (brown), F. prausnitzi (blue), and E. rectale (green). The heatmap shows the p
levels (each row associated with the corresponding species indicated in the left part of the figure). Data a
biomass.
(C) A diet algorithm was developed and implemented for prediction of the macromolecules present in differen
of diets to three main categories of macronutrients carbohydrates, fiber, and amino acids.
See Tables S5, S6, and S7.
Cell Metabolism 22, 320–3also enabled understanding of metabolic
shifts under different clinical conditions
and hereby could provide a direct link be-
tween the gut microbiome metabolism
and serum chemistry.
Thus, our simulations suggest that the
gut microbiome may contribute to altered
levels of several amino acids in the serum,
including phenylalanine and branched-
chain amino acids. This is in line with an
early report, using germ-free mice,
showing that the microbiota of the large
intestine increased the free amino acid
level in the gastrointestinal tract (Macfar-
lane et al., 1988). A later study showed
that bacteria in the human large intestine
take up peptides and amino acids and
convert these to different amino acids
and SCFAs (Smith and Macfarlane,1998). This study also showed that the production of amino acids
was dependent on the composition of starch, proteins, and pep-
tides and, hence, will be dependent on the dietary composition.
Further confirmation of our findings is documented in a recent
review on the role of microbial amino acid metabolism in host
metabolism that provides a summary on a number of findings
related to the role of the microbiota in the large intestine on
production of not only SCFAs but also amino acids that areplots with E. coli (red),B. thetaiotaomicron (yellow),
values for four different comparisons of the species
re presented as mean ± SD. grBiomass, grams of
t food sources, and this allowed further conversion
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A B
C
Figure 6. The Serum Metabolomics Vali-
dated the Predictions and Fecal Metabolo-
mics
(A) Metabolomics of the serum samples obtained
from HGC and LGC individuals. The ten amino
acids and acetate were quantified at the baseline
and at week 6.
(B) p values based on Student’s t test for specifi-
cation of significantly changed metabolites be-
tween HGC and LGC at baseline and week 6.
(C) Correlation of the ten quantified amino
acids in serum with different clinical parameters
of HGC and LGC subjects. The figure shows
significant correlations (p < 0.05), with the color
code specifying the slope of the correlation.
Fat mass was measured by biphotonic absorp-
tiometry (DXA). MIP1b, macrophage inflam-
matory protein 1b; sCD14, soluble CD14; hsCRP,
human sensitive CRP; HOMA-IR, homeo-
static model assessment  insulin resistance =
Glucose 3 Insulin=22:5 ; BMI, body mass index
(kg/m2); Disse index = 123 ½2:5 3 ðHDL=Total
CholesterolÞ  FFA  Insulin; MIP1b: macro-
phage inflammatory protein 1b; hsCRP, human
sensitive CRP; NEFA, non-esterified fatty acids.
See also Table S4.subsequently taken up by the host (Neis et al., 2015). However,
further experiments are required to validate the direct contribu-
tion of the gut microbiome to host amino acid metabolism.
In our study, obese individuals with a LGC microbiome, asso-
ciated with more impaired metabolic phenotype compared with
those with HGC, had elevated levels of these amino acids.
A previous study has shown that phenylalanine is associated
with type 2 diabetes (T2D), and serum levels of this essential
amino acid are 5- to 7-fold higher in individuals at risk of T2D
compared to control subjects (Wang et al., 2011). Furthermore,
the serum level of branched-chain amino acids (valine, leucine,
and isoleucine) has been found to correlate with insulin resis-
tance (Newgard et al., 2009). Circulating levels of leucine, argi-Tr
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328 Cell Metabolism 22, 320–331, August 4, 2015 ª2015 Elsevier Incnine, valine, proline, phenylalanine, isoleucine, and lysine are
also significantly associated with an increased risk of hypertrigly-
ceridemia in diabetic subjects (Mook-Kanamori et al., 2014), a
phenotype we noted in the subjects with the LGC microbiome.
Thus, our simulations point to two important findings. First,
they suggest that the gut microbiota in LGC individuals may
contribute to increased serum levels of many amino acids that
have been found correlated with metabolic diseases such as
T2D, and we believe that this is consistent with the deteriorated
glucose homeostasis related to insulin resistance observed
for the LGC subjects at baseline both in French and Danish
subjects (Cotillard et al., 2013; Le Chatelier et al., 2013). The
HGC subjects, on the other hand, with their more gene-richE
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Figure 7. Modeling the Dietary Composition
to Transfer LGC Individuals toward
Improved Phenotype
(A) The yellow circles specify the simulated
consumption of the eight essential amino acids
by the gut microbiome of the LGC individuals
at baseline (base phenotype), and the green
circles specify the simulated consumption of
the eight essential amino acids for the HGC
individuals at week 6 (improved phenotype).
(B) After calculating the required amount of
eight essential amino acids at baseline and
improved phenotype, both patterns were
correlated with composition of amino acids
in different food categories. The direction of
the CorrImproved  CorrBase indicates the positive/
C subjects. CorrBase, correlation between pattern amino acids in base
proved phenotype and food).
.
gut microbiome, may have a better conversion of amino acids,
resulting in lower levels of these in the plasma. Furthermore,
the HGC microbiome also has a higher capacity to produce
SCFAs that not only are important energy sources for the colo-
nocytes but also function as signaling molecules, modulating
intestinal inflammation and metabolism (Donohoe et al., 2011;
Fernandes et al., 2014; Samuel et al., 2008; Smith et al.,
2013b; Tolhurst et al., 2012). Second, in agreement with the
original study on the LGC in comparison to the HGC individ-
uals, our simulations highlight the finding that LGC subjects
can benefit from a dietary intervention that improves their gut
microbiome metabolism, paving the way for a personalized
approach in these subjects. Indeed, despite higher levels of
some amino acids at baseline, LGC subjects had a larger
decrease in the levels of a range of metabolites that are posi-
tively correlated with insulin resistance markers and cardiome-
tabolic risk factors.
Using our approach, we also predicted the relative contribu-
tion of each bacterial species to the production of specific me-
tabolites and studied how this variation in the gut microbiome
is correlated with specific metabolite production. Information
generated from CASINO may, therefore, be extended for
rational design of prebiotics as well as for identifying novel bene-
ficial bacteria that can be used to fortify the microbiota to
improve the gut microbiome metabolism. Importantly, rational
design of microbiota interventions requires knowledge of diet,
as demonstrated in a study of children with kwashiorkor, which
showed that a disrupted microbiome can be reversed by dietary
interventions (Smith et al., 2013a). Interestingly, transferring
the microbiota from children with kwashiorkor to germ-free
mice in combination with a Malawian diet resulted in marked
weight loss in recipient mice associated with perturbations in
amino acids. As we demonstrated, CASINO can also be used
to predict dietary changes required to ensure a certain profile
of the gut metabolism, here represented as a specific consump-
tion of eight essential amino acids. The gut microbiome may
change in response to dietary modulation, something that our
simulations are not capturing. This study also emphasizes the
importance of developing accurate tools to properly record
dietary intakes in different populations. With more data, it will
probably be possible to also predict how the diet influences
gut microbiome changes, and CASINO may hereby assist in
the development of a precision medicine approach to treat
metabolic diseases associated with dysfunction of the gut
microbiota.
In conclusion, we demonstrate how we can use model sim-
ulations to predict metabolic interactions within the gut micro-
biome and hereby assist in generating mechanistic insight into
the contribution of individual species of the gut microbiome
to the overall metabolism of the ecosystem and the host.
Furthermore, focused on the diet and on host and gut micro-
biota metabolic interactions, we show how the gut ecosystem
and the individual members of the gut microbiota contribute
to the host metabolism. CASINO may thus constitute a valuable
tool for enriching the information content provided by gut
metagenome analysis, hereby advancing our understanding
on how this important metabolic organ contributes to disease
development, and thus facilitate personalized interventions
based on the microbiome.CelEXPERIMENTAL PROCEDURES
Reconstruction/Updating of GEMs
The B. adolescentis, B. thetaiotaomicron, E. rectale, and F. prausnitzii meta-
bolic models were already published (El-Semman et al., 2014; Shoaie et al.,
2013).These models were validated individually and updated based on exten-
sive bibliometric survey of the literature and databases (Henry et al., 2010). The
R. bromii and L. reuteri metabolic networks were reconstructed based on
automatic and manual curation, considering information available in the litera-
ture and databases. For model reconstructions, updating and quality checks,
the RAVEN toolbox was used (Agren et al., 2013). The defined metabolic task
file was implemented to perform the gap-filling process. This task file includes
synthesis of amino acids, nucleotides, and carbohydrates. A published meta-
bolic model for E. coli was used for simulation (Monk et al., 2013).
Validation of GEMs
The metabolic models for B. adolescentis, B. thetaiotaomicron, E. rectale,
F. prausnitzii, and R. bromiiwere used to predict the experimental phenotypes
based on the individual in vitro data. The growth for each model was predicted
as an objective function based on the available media components from the
experiments. Measured amino acids and SCFAs secretion were used to
constrain the models for individual simulations. The lower and upper bounds
for the uptake and secretion reactions were assigned based on the SD of
the measured metabolites in experimental data. The results were tested to
determine the consistency of the model through fixation of non-growth-asso-
ciated maintenance ATP.
CASINO Toolbox
CASINO defines the primary topology of the community and identifies an
optimum solution by applying a multi-dimensional optimization procedure in
two successive and connected stages: initialization and community optimiza-
tion. The convexity of the solution space and linearity of the parameters are
maintained by separating the problem into two independent optimizing dimen-
sions, systems level and organism level, with three classes of variables: inputs,
outputs, and connecting parameters. Maximum biomass production was
considered as the objective function at both levels. At the organism level,
each species seeks to maximize its biomass yield, while at the system level,
the community seeks to stay in the optimum balanced condition by synchro-
nizing the competition between species (Figure S1).
The initialization process assumes a structure of the community as a com-
plex network and starts with an activation cascade supporting a specific
threshold. Species are categorized into primary (grows independently by
taking up system-level inputs) and non-primary (growth is dependent on
connecting inputs, i.e., metabolites produced by other species) classes. The
activation begins with identifying primary species within the community and
activates them by providing required resources to grow. The compounds pro-
duced by activated species are added to the resource pool, and the commu-
nity is screened again to find non-primary species that now can grow based on
the updated resource pool. This cascade of activation is repeated until the
whole network has been activated. Now, a feasible profile of community topol-
ogy is constructed, and this results in a definition of the community constraints
matrix and the community objective function. At the end of the initialization
process, the system is locally optimum (species grow on maximum biomass
yield rate) but globally non-optimum (resources distribution between species
do not satisfy community optimum conditions).
Community optimization, a multi-level iterative process, starts based on the
initial feasible space and a community objective function defined by the initial-
ization procedure. In each step, the community-level biomass production is
optimized to find the optimum distribution of resources between species.
Relative carbohydrate uptake rates are calculated in each intermediate
systems-level optimum condition, and these are used by the species to reach
organism-level optimality. Metabolite secretion rates obtained after organism-
level optimization is used to expand the boundaries of the intermediate
feasible space and find a new systems-level optimum. This iterative process
continues until the solution converges to local and global optima.
Objective function in this algorithm is considered asmaximumbiomass yield
(local force) at the organism level and maximum community biomass (commu-
nity force) at the systems level. Summation of these two forces defines thel Metabolism 22, 320–331, August 4, 2015 ª2015 Elsevier Inc. 329
direction of optimization through expansion of the feasible space. The commu-
nity force is adjusted by centrality scores assigned to each species based on
the network topology of the community established in the initialization proce-
dure. Two centrality degrees, power centrality and degree centrality, are used
to calculate controlling power of species as effectors and receptors.
Maximize S= ½4 3 q0 : CE : um:d;
where
s = a:X + b:Zin +g:Y + d:Zout
um =
mðiÞ
minðmPLÞ
4= ½a; b; g; d : Coefficients matrix
q= ½X; Y ; Z : Inputs; outputs and connecting parameters
PL : Primary species list :
d is a binary vector that activates certain parameter in the objective equation.
This binary vector is corrected by imposing the relative centrality scores of
species. m(i) is the biomass yield of individuals, and mPL is biomass yield of
species belonging to PL.
Statistical Analysis
Peaks obtained from 144 samples (HGC and LGC subjects) at two different
time points (0 hr and 6 weeks) were aligned and subjected to retention time
correction using XCMS (Smith et al., 2006). About 295 features (m/z; mass-
to-charge ratio) with aligned peaks were normalized by the quantile normaliza-
tion method (Amaratunga and Cabrera, 2001). Mass fragmentation spectra of
each featured peak werematched against the reference spectra obtained from
METLIN (Tautenhahn et al., 2012) and the Human Metabolome Database
(HMDB) (Wishart et al., 2013), using the exact template-matching approach
(Pavlidis, 2003). Spectra with 90% match probability were considered for
further analysis. Again, the retention index of the matched peak(s) (m/z) was
verified with metabolites in HMDB (Wishart et al., 2013). Thus, spectral match
and retention index ensure identification and annotation of metabolites.
Intensity (or expression) of 15 metabolites of interest was extracted for HGC
and LGC subjects at two time points. Two sample t tests were performed
for detecting the significant metabolites, and a p value < 0.05 was considered
to be significant. All data are shown as mean ± 1 SD.
SUPPLEMENTAL INFORMATION
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